Cas 134557-08-7,ethyl 5-cyano-2-methyl-6-oxo-4-(2-nitrophenyl)-1,4,5,6-tetrahydropyridine-3-carboxylate

134557-08-7

Post Buying Request

Basic information

Product Name: ethyl 5-cyano-2-methyl-6-oxo-4-(2-nitrophenyl)-1,4,5,6-tetrahydropyridine-3-carboxylate
Synonyms: ethyl 5-cyano-2-methyl-6-oxo-4-(2-nitrophenyl)-1,4,5,6-tetrahydropyridine-3-carboxylate
CAS NO:134557-08-7
Molecular Formula:
Molecular Weight: 329.312
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: ethyl 5-cyano-2-methyl-6-oxo-4-(2-nitrophenyl)-1,4,5,6-tetrahydropyridine-3-carboxylate(CAS DataBase Reference)
NIST Chemistry Reference: ethyl 5-cyano-2-methyl-6-oxo-4-(2-nitrophenyl)-1,4,5,6-tetrahydropyridine-3-carboxylate(134557-08-7)
EPA Substance Registry System: ethyl 5-cyano-2-methyl-6-oxo-4-(2-nitrophenyl)-1,4,5,6-tetrahydropyridine-3-carboxylate(134557-08-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 134557-08-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

134557-08-7 Suppliers

Recommended suppliers

134557-08-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 134557-08-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,5,5 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 134557-08:
(8*1)+(7*3)+(6*4)+(5*5)+(4*5)+(3*7)+(2*0)+(1*8)=127
127 % 10 = 7
So 134557-08-7 is a valid CAS Registry Number.

134557-08-7Upstream product

134557-08-7Downstream Products

134557-08-7Relevant academic research and scientific papers

Design, synthesis and ex vivo study of the vasorelaxant activity induced by isosteric derivatives of dihydropyridines (NH-O)

Rendón-Vallejo, Priscila,Estrada-Soto, Samuel,Vázquez, Miguel A.,Hernández-Borja, Fernando,Villalobos-Molina, Rafael,Ibarra-Barajas, Maximiliano

, p. 353 - 359 (2016)

Background: Hypertension is a complex and multifactorial disorder that is an important cause of morbidity and mortality in all around the world; and the rationalized structural modification of drugs represents an important strategy for to develop new anti

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 134557-08-7